HANNAH SCHMIDT: Open Payments
NPI 1801500988 · EMPORIA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,145 in 120 payments from 37 companies in 2025. Trend: 2023 $1,307 · 2024 $2,590 · 2025 $2,145
Food & beverage: $2,095Education: $50
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $288 |
| Novartis Pharmaceuticals Corporation | 15 | $188 |
| ABBVIE INC. | 9 | $171 |
| Genentech USA, Inc. | 10 | $160 |
| AstraZeneca Pharmaceuticals LP | 8 | $156 |
| Gilead Sciences, Inc. | 5 | $109 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| Daiichi Sankyo Inc. | 4 | $88 |
| TerSera Therapeutics LLC | 3 | $86 |
| PFIZER INC. | 3 | $58 |
Products named: ENHERTU, ERLEADA, Trodelvy, Zoladex, ELAHERE, Itovebi, JEMPERLI, KISQALI.
Industry payments across KS — which companies pay providers there.
